Cargando…
Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
Background: Hepatocellular carcinoma (HCC) is a serious complication of cirrhosis. Currently, non-selective beta-blockers (NSBBs) are commonly used to treat portal hypertension in patients with cirrhosis. The latest research shows that NSBBs can induce apoptosis and S-phase arrest in liver cancer ce...
Autores principales: | He, Xinyi, Zhao, Zimo, Jiang, Xi, Sun, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394622/ https://www.ncbi.nlm.nih.gov/pubmed/37538177 http://dx.doi.org/10.3389/fphar.2023.1216059 |
Ejemplares similares
-
Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
por: Cheng, He-Yun, et al.
Publicado: (2022) -
Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
por: Zhao, Zimo, et al.
Publicado: (2023) -
Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014) -
Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study
por: Liu, Sheng-Fu, et al.
Publicado: (2021) -
Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2022)